exciting updates in all and the value of novel immunotherapies
Published 1 year ago • 91 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
2:01
the evolution of bcl2 inhibition in cll
-
1:46:07
hematology lecture
-
9:25
mgus diagnosis: a step-by-step approach
-
21:38
drawing the line: the rationale behind blood tube collection order
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
0:54
a research update in richter's transformation from ash 2023
-
0:41
isct in bringing together the scientific community
-
2:57
exciting research in aml and important considerations for the future
-
1:39
session highlights: the value of clinical hematology research groups
-
2:41
an overview of the latest advances in hematology
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
1:02
the impact of sequencing in aml
-
0:58
current research and next steps to improve the understanding and management of icaht
-
2:09
heart transplantation in attr amyloidosis